Novavax Inc. sell JPMorgan Chase & Co.
Start price
09.05.25
/
50%
€5.45
Target price
09.05.26
€6.24
Performance (%)
59.39%
End price
10.05.26
€8.69
Summary
This prediction ended on 10.05.26 with a price of €8.69. The price for Novavax Inc. massively increased, which is bad news for the SELL prediction by JPMorgan_Chase___Co_. JPMorgan_Chase___Co_ has a follow-up prediction for Novavax Inc. where he still thinks Novavax Inc. is a Sell. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novavax Inc. | -4.631% | -4.631% | 3.682% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Novavax Inc. diskutieren
Novavax, Inc. (NASDAQ: NVAX) had its price target lowered by analysts at JPMorgan Chase & Co. from $9.00 to $7.00. They now have an "underweight" rating on the stock.
Ratings data for NVAX provided by MarketBeat
In the thread Trading Novavax Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten